Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Jerusalem Pharmaceuticals Ratios and Metrics

Market cap in millions JOD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	59	49	49	42	36	35
Market Cap Growth	40.59%	0.69%	15.82%	16.13%	2.15%	-1.04%
Enterprise Value	53	43	41	39	37	39
Last Close Price	3.29	2.66	2.57	2.14	1.77	1.69
PE Ratio	8.49	13.68	9.83	8.23	7.72	13.39
PS Ratio	1.77	1.73	1.73	1.28	1.10	1.37
PB Ratio	1.01	0.96	0.99	0.91	0.74	0.81
P/TBV Ratio	1.05	1.00	1.03	0.94	0.80	0.89
P/FCF Ratio	21.59	6.94	8.72	3.62	13.20	111.66
P/OCF Ratio	13.70	5.87	7.44	3.47	8.42	26.14
EV/Sales Ratio	1.60	1.52	1.47	1.18	1.12	1.50
EV/EBITDA Ratio	5.79	7.64	5.73	5.19	5.20	9.16
EV/EBIT Ratio	6.74	9.05	6.49	6.20	6.48	13.58
EV/FCF Ratio	19.48	6.10	7.44	3.35	13.40	122.00
Debt / Equity Ratio	0.03	0.02	0.04	0.03	0.04	0.06
Debt / EBITDA Ratio	0.16	0.18	0.23	0.20	0.25	0.61
Debt / FCF Ratio	0.55	0.15	0.32	0.13	0.68	8.62
Asset Turnover	0.49	0.45	0.47	0.54	0.56	0.49
Inventory Turnover	2.08	2.10	1.72	1.79	1.61	1.40
Quick Ratio	2.54	3.34	2.97	2.88	2.80	2.49
Current Ratio	3.52	4.29	4.11	3.86	4.25	4.18
Return on Equity (ROE)	13.14%	7.21%	10.45%	10.77%	9.55%	6.30%
Return on Assets (ROA)	7.32%	4.77%	6.60%	6.45%	6.06%	3.38%
Return on Invested Capital (ROIC)	13.30%	8.14%	11.48%	11.22%	10.07%	6.48%
Return on Capital Employed (ROCE)	12.50%	8.70%	12.10%	12.60%	10.80%	6.00%
Earnings Yield	11.79%	7.31%	10.17%	12.15%	12.95%	7.47%
FCF Yield	4.63%	14.42%	11.46%	27.64%	7.58%	0.90%
Dividend Yield	1.72%	2.14%	2.76%	4.98%	4.80%	3.36%
Payout Ratio	14.34%	33.52%	36.63%	29.90%	20.25%	44.33%
Buyback Yield / Dilution	-0.23%	-	-	-	-	-
Total Shareholder Return	1.49%	2.14%	2.76%	4.98%	4.80%	3.36%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.